We are live on ! Find out more
REVB icon

Revelation Biosciences
REVB

7 hedge funds and large institutions have $31.7M invested in Revelation Biosciences in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

45% less capital invested

Capital invested by funds: $57.5M → $31.7M (-$25.8M)

50% less funds holding

Funds holding: 14 → 7 (-7)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 7

Holders
7
Holders Change
-7
Holders Change %
-50%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WRBC
W.R. Berkley Corp
Connecticut
+$2.04M

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$6.64M
2
MSU
Mizuho Securities USA
New York
-$4.09M
3
GCL
Glazer Capital LLC
New York
-$4.07M
4
CH
CVI Holdings
Delaware
-$3.02M
5
Millennium Management
Millennium Management
New York
-$2.99M

REVB Hedge Fund Activity: Q4 2021 in Review

7 of the 6,517 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences (REVB) for Q4 2021, worth a combined $31.7M — down 45% from $57.5M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of REVB and 0 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was W.R. Berkley Corp, adding an estimated $2.04M. The largest seller was Linden Advisors, exiting entirely with an estimated $6.64M sold.

  • 7 institutional investors held Revelation Biosciences (REVB) as of Q4 2021, down from 14 in Q3 2021.
  • Funds reported $31.7M of Revelation Biosciences stock for Q4 2021, down 45% quarter-over-quarter.
  • 0 funds opened new Revelation Biosciences positions in Q4 2021 and 7 closed out, a net change of -7 holders.
  • The largest Revelation Biosciences buyer in Q4 2021 was W.R. Berkley Corp, an estimated $2.04M added.
  • The largest Revelation Biosciences seller in Q4 2021 was Linden Advisors, an estimated $6.64M sold.

Based on aggregated 13F filings for Q4 2021.